Smofkabiven 0.17 g

SMOFKABIVEN 0.17 G is an intravenous emulsion containing sodium acetate trihydrate, used for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is available in various pack sizes.

SMOFKABIVEN 0.17 G is primarily used for intravenous nutrition, providing essential nutrients to patients who cannot consume food orally. It is often utilized in clinical settings to support patients with specific nutritional needs, such as those undergoing certain medical treatments or recovering from surgery. The emulsion helps maintain proper electrolyte balance and supports overall health.

When administered intravenously, SMOFKABIVEN 0.17 G provides nutrients directly into the bloodstream, which can help improve nutritional status. Patients may experience improved energy levels and overall well-being as the body utilizes the provided nutrients. However, individual responses can vary, and it is important to monitor for any adverse reactions.

SMOFKABIVEN 0.17 G should be administered under the supervision of a healthcare professional. It is crucial to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with certain medical conditions or allergies should inform their healthcare provider before use. Always check the packaging for any specific precautions related to the product.

SMOFKABIVEN 0.17 G may interact with other medications or supplements, particularly those that affect electrolyte balance. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol and certain foods may influence the effectiveness of the emulsion, so it is advisable to follow a healthcare professional's guidance on diet and lifestyle during treatment.